Last 7 days
-8.0%
Last 30 days
-11.2%
Last 90 days
-15.5%
Trailing 12 Months
-52.8%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-08-17 | ZIEGLER JOSEPH | acquired | - | - | 7,500 | principal financial officer |
2023-06-28 | Rubric Capital Management LP | acquired | 1,150,000 | 3.6797 | 312,525 | - |
2023-04-26 | Walker Marlan D | sold | -2,517 | 3.6381 | -692 | chief executive officer |
2023-04-26 | Walker Marlan D | acquired | - | - | 2,744 | chief executive officer |
2023-04-12 | Walker Marlan D | sold | -4,275 | 3.6543 | -1,170 | chief executive officer |
2023-04-12 | Walker Marlan D | acquired | - | - | 7,508 | chief executive officer |
2023-04-12 | Donegan Michael C | acquired | - | - | 50,000 | prin. fin. and acctg. officer |
2023-01-27 | Donegan Michael C | sold | -249 | 5.09 | -49.00 | prin. fin. and acctg. officer |
2023-01-26 | Donegan Michael C | acquired | - | - | 5,940 | prin. fin. and acctg. officer |
2023-01-26 | Donegan Michael C | sold | -8,371 | 5.0796 | -1,648 | prin. fin. and acctg. officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-21 | OSAIC HOLDINGS, INC. | added | 584 | 12,634 | 14,571 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | reduced | -12.99 | -69.00 | 1,462 | -% |
2023-08-15 | Clearline Capital LP | added | 8.57 | 303,289 | 1,876,130 | 0.11% |
2023-08-15 | HARBOUR INVESTMENTS, INC. | unchanged | - | 3.00 | 33.00 | -% |
2023-08-14 | Guardian Wealth Management, Inc. | unchanged | - | - | 8.00 | -% |
2023-08-14 | CITADEL ADVISORS LLC | new | - | 499 | 499 | -% |
2023-08-14 | Royal Bank of Canada | added | 73.95 | 2,000 | 5,000 | -% |
2023-08-14 | VANGUARD GROUP INC | unchanged | - | 142,541 | 1,587,220 | -% |
2023-08-14 | STATE STREET CORP | reduced | -0.01 | 11,139 | 124,127 | -% |
2023-08-14 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | 15,540 | 173,040 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jun 30, 2023 | rubric capital management lp | 19.57% | 2,069,716 | SC 13D/A | |
Aug 30, 2022 | rubric capital management lp | 18.27% | 1,721,953 | SC 13D/A | |
Jul 08, 2022 | blackrock inc. | 1.4% | 122,138 | SC 13G/A | |
Jun 03, 2022 | beryl capital management llc | 1.5% | 126,229 | SC 13G | |
Mar 23, 2022 | smith robert j | 5.38% | 23,103,292 | SC 13D/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 0.1% | 649,807 | SC 13G/A | |
Feb 01, 2022 | blackrock inc. | 5.9% | 24,894,812 | SC 13G/A | |
Jul 07, 2021 | flynn james e | 4.90% | 20,662,810 | SC 13G | |
Feb 16, 2021 | price t rowe associates inc /md/ | 6.2% | 18,869,212 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 4.39% | 13,165,644 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Aug 21, 2023 | 4 | Insider Trading | |
Aug 21, 2023 | 3 | Insider Trading | |
Aug 18, 2023 | 8-K | Current Report | |
Aug 14, 2023 | 8-K | Current Report | |
Aug 14, 2023 | 10-Q | Quarterly Report | |
Jul 19, 2023 | 4 | Insider Trading | |
Jul 19, 2023 | 4 | Insider Trading | |
Jul 19, 2023 | 4 | Insider Trading | |
Jul 11, 2023 | D | D | |
Jul 10, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
LLY | 517.3B | 29.5B | 5.22% | 88.98% | 79.61 | 17.53 | 1.53% | 14.16% |
JNJ | 421.5B | 97.8B | -5.97% | -1.12% | 32.29 | 4.31 | 2.29% | -28.92% |
MRK | 272.8B | 58.3B | -1.68% | 25.60% | 17.88 | 4.63 | 2.00% | -81.24% |
PFE | 191.9B | 77.9B | -7.28% | -24.56% | 8.94 | 2.46 | -23.04% | -26.74% |
BMY | 150.1B | 45.2B | -5.53% | -15.83% | 23.72 | 3.25 | -4.15% | 20.34% |
MID-CAP | ||||||||
RETA | 6.5B | - | 1.68% | 536.50% | -74 | 4.1K | -86.94% | 71.24% |
PRGO | 4.5B | 4.6B | -12.08% | -16.86% | -67.03 | 0.98 | 6.60% | 42.04% |
SMALL-CAP | ||||||||
TLRY | 1.9B | 627.1M | -7.75% | -1.79% | -1.34 | 3.1 | -0.20% | -204.67% |
SUPN | 1.5B | 634.0M | -8.17% | -19.68% | 35.6 | 2.43 | 0.62% | -24.59% |
CRON | 842.2M | 109.5M | 18.82% | -27.78% | -5.87 | 7.69 | -2.66% | -32.13% |
INVA | 814.0M | 244.3M | -8.50% | 0.08% | 4.13 | 3.33 | -39.50% | -4.99% |
CGC | 567.0M | 453.3M | 123.19% | -68.11% | -0.46 | 1.25 | -16.04% | 55.90% |
PAHC | 505.9M | 977.9M | -17.56% | -11.73% | 15.52 | 0.52 | 3.78% | -33.69% |
OPNT | 106.7M | - | 2.08% | -28.79% | -3.22 | 2.72 | - | - |
TXMD | 35.2M | - | -11.20% | -52.83% | 0.82 | 0.55 | -19.54% | 257.52% |
-31.0%
-48.1%
-60.3%
-64.2%
100%
99.6%
96.9%
Y-axis is the maximum loss one would have experienced if TherapeuticsMD was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | - | - | - | 69,963,000 | 69,235,333 | 68,507,667 | 67,780,000 | 86,951,000 | 90,851,000 | 84,787,000 | 72,487,000 | 64,872,000 | 58,196,000 | 62,573,000 | 57,951,000 | 49,647,000 | 38,834,000 | 18,588,535 | 16,272,545 | 16,098,937 | 15,134,937 | 16,079,402 |
Gross Profit | 1.4% | 31,125,000 | 30,688,000 | 68,566,000 | 45,543,000 | 48,538,000 | 67,407,000 | 68,113,000 | 71,169,000 | 67,108,000 | 54,540,000 | 48,897,000 | 44,923,000 | 51,135,000 | 49,664,000 | 43,312,000 | 34,428,000 | 14,928,000 | 13,407,000 | 13,362,000 | 12,753,000 | 13,695,000 |
Operating Expenses | -612.4% | -9,997,000 | 1,951,000 | 67,375,000 | -7,194,000 | 14,975,000 | 54,166,000 | 80,748,000 | 210,154,000 | 191,146,000 | 188,437,000 | 204,438,000 | 210,248,537 | 218,558,220 | 213,686,098 | 194,517,000 | 179,361,869 | 167,150,850 | 157,014,725 | 143,581,978 | 126,532,660 | 107,945,721 |
S&GA Expenses | -35.8% | 21,166,000 | 32,960,000 | 57,903,000 | 45,805,000 | 56,681,000 | 74,270,000 | 80,748,000 | 112,189,000 | 104,557,000 | 102,280,000 | 117,052,000 | 102,301,481 | 125,055,467 | 136,555,918 | 114,231,000 | 156,789,394 | 142,016,480 | 130,095,799 | 115,988,954 | 94,757,037 | 76,460,833 |
R&D Expenses | - | - | - | - | 5,512,000 | 6,005,000 | 6,436,000 | 7,086,000 | 8,060,000 | 8,482,000 | 9,213,000 | 10,432,000 | 12,470,012 | 14,520,750 | 16,743,118 | 19,792,000 | 22,113,178 | 24,743,711 | 26,577,723 | 27,299,138 | 31,520,904 | 31,249,435 |
EBITDA | -100.0% | - | 47,859,000 | 15,812,000 | 34,325,000 | 18,810,000 | -142,449,000 | -135,405,000 | -139,166,967 | -124,138,180 | -133,974,925 | -153,900,924 | -163,212,450 | -164,765,792 | -171,165,387 | -158,149,998 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.68 | 0.23 | 0.39 | 0.20 | -1.65 | -1.56 | -1.53 | -1.46 | -1.85 | -2.37 | -2.80 | -2.63 | -2.95 | -3.19 | - | - | - | - | - | - |
Interest Expenses | 0.4% | -12,427,000 | -12,472,000 | 13,545,000 | 9,924,000 | 12,609,000 | 20,205,000 | 25,068,000 | 32,953,000 | 33,115,000 | 32,546,000 | 28,581,000 | 26,633,368 | 24,552,373 | 21,553,982 | 17,382,000 | 13,811,007 | 10,265,079 | 6,767,852 | 4,677,834 | 5,168,918 | 2,125,528 |
Earnings Before Taxes | 15.6% | -67,460,000 | -79,919,000 | 1,074,000 | -11,823,000 | -30,018,000 | -57,797,000 | -79,305,000 | -171,542,000 | -156,734,000 | -166,058,000 | -183,524,000 | -190,872,515 | -190,227,108 | -193,487,625 | -176,145,000 | -166,100,466 | -169,739,175 | -147,721,706 | -132,617,160 | -114,653,509 | -93,712,848 |
EBT Margin | -100.0% | - | 0.68 | 0.02 | -0.10 | -0.29 | -2.11 | -1.98 | -1.89 | -1.85 | -2.29 | -2.83 | -3.28 | -3.04 | -3.34 | -3.55 | - | - | - | - | - | - |
Net Income | -72.9% | 42,720,000 | 157,415,000 | 111,997,000 | -8,665,000 | -27,120,000 | -182,053,000 | -172,415,000 | -171,542,000 | -156,734,000 | -166,058,000 | -183,524,000 | -190,872,000 | -190,227,000 | -193,488,000 | -176,145,000 | -166,101,000 | -169,739,000 | -147,721,000 | -132,617,000 | -114,653,000 | -93,713,000 |
Net Income Margin | -100.0% | - | 2.25 | 1.60 | -0.10 | -0.29 | -2.11 | -1.98 | -1.89 | -1.85 | -2.29 | -2.83 | -3.28 | -3.04 | -3.34 | -3.55 | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 18,530,000 | 9,359,000 | -103,429,000 | -122,661,000 | -133,852,000 | -142,727,000 | -133,658,959 | -129,603,000 | -158,988,174 | -159,677,408 | -180,311,148 | -173,468,453 | -168,854,278 | -168,147,880 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | -9.9% | 54.00 | 60.00 | 90.00 | 134 | 146 | 133 | 169 | 210 | 211 | 239 | 182 | 177 | 206 | 269 | 266 | 250 | 247 | 182 | 212 | 237 | 172 |
Current Assets | -20.7% | 20.00 | 25.00 | 55.00 | 87.00 | 99.00 | 84.00 | 119 | 160 | 160 | 187 | 128 | 122 | 149 | 212 | 208 | 192 | 216 | 153 | 187 | 212 | 167 |
Cash Equivalents | 0% | 49.00 | 49.00 | 38.00 | 38.00 | 65.00 | 65.00 | 79.00 | 105 | 111 | 138 | 80.00 | 80.00 | 114 | 170 | 161 | 155 | 183 | 123 | 162 | 190 | 154 |
Inventory | - | - | - | - | 7.00 | 6.00 | 9.00 | 8.00 | 7.00 | 8.00 | 7.00 | 8.00 | 10.00 | 10.00 | 15.00 | 12.00 | 11.00 | 7.00 | 5.00 | 3.00 | 2.00 | 2.00 |
Net PPE | -32.8% | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 2.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 |
Liabilities | -18.4% | 22.00 | 28.00 | 55.00 | 182 | 172 | 274 | 263 | 267 | 260 | 249 | 306 | 293 | 300 | 314 | 257 | 271 | 238 | 121 | 114 | 103 | 94.00 |
Current Liabilities | -25.7% | 14.00 | 19.00 | 47.00 | 174 | 164 | 265 | 253 | 86.00 | 76.00 | 61.00 | 59.00 | 47.00 | 46.00 | 62.00 | 53.00 | 67.00 | 42.00 | 45.00 | 41.00 | 29.00 | 21.00 |
LT Debt, Current | - | - | - | - | 94.00 | 91.00 | 203 | 188 | 15.00 | 10.00 | 5.00 | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | 172 | 175 | 179 | 238 | 237 | 244 | 243 | 195 | 194 | 194 | 74.00 | 73.00 | 73.00 | 73.00 |
Shareholder's Equity | -2.6% | 31.00 | 32.00 | 35.00 | - | -26.07 | -140 | -93.62 | - | - | - | - | - | - | - | 9.00 | - | 8.00 | 61.00 | 98.00 | 134 | 78.00 |
Retained Earnings | -0.3% | -945 | -942 | -939 | -1,017 | -988 | -1,100 | -1,051 | -1,008 | -960 | -918 | -878 | -836 | -804 | -752 | -695 | -645 | -614 | -558 | -519 | -479 | -444 |
Additional Paid-In Capital | 0.2% | 977 | 975 | 974 | 969 | 962 | 960 | 958 | 951 | 912 | 908 | 755 | 721 | 710 | 707 | 704 | 625 | 622 | 619 | 617 | 614 | 522 |
Shares Outstanding | 10.8% | 11.00 | 10.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | 8.00 | 8.00 | 7.00 | 6.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 |
Cashflow (Last 12 Months) | (In Thousands) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 93.5% | 35,859 | 18,530 | 9,359 | -15,848 | -28,814 | -34,625 | -55,133 | -133,492 | -129,318 | -158,740 | -159,471 | -179,931 | -172,105 | -166,665 | -165,718 | -143,045 | -150,890 | -125,325 | -106,811 | -99,472 | -82,088 |
Share Based Compensation | -18.0% | 8,198 | 9,994 | 11,572 | 13,933 | 16,953 | 17,229 | 18,125 | 14,956 | 10,777 | 11,270 | 10,679 | 11,325 | 10,827 | 10,461 | 10,682 | 10,133 | 9,758 | 9,498 | 8,662 | 8,240 | 7,966 |
Cashflow From Investing | - | - | - | -355 | 140,802 | -1,984 | -1,997 | -2,223 | -1,203 | -1,283 | -1,593 | -1,598 | -21,817 | -22,857 | -23,669 | -23,892 | -3,849 | -22,882 | -21,983 | -21,497 | -21,178 | -915 |
Cashflow From Financing | -Infinity% | -220,412 | - | -235,206 | -103,905 | -91,825 | 28,603 | 129,552 | 159,902 | 128,186 | 127,852 | 80,725 | 126,053 | 125,956 | 237,549 | 188,827 | 112,226 | 202,232 | 162,843 | 162,787 | 162,357 | 140,915 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Total revenue, net | $ 437 | $ 348 | $ 853 | $ 1,043 |
Cost of revenue | 348 | 1,043 | ||
Gross profit | 437 | 0 | 853 | 0 |
Operating expenses: | ||||
Selling, general and administrative | 2,781 | 14,575 | 5,837 | 32,121 |
Depreciation & amortization | 128 | 282 | 155 | 611 |
Total operating expenses | 2,909 | 14,857 | 5,992 | 32,732 |
Loss from operations | (2,472) | (14,857) | (5,139) | (32,732) |
Other (expense) income: | ||||
Interest expense and other financing costs | (45) | 0 | (95) | 0 |
Miscellaneous income (expense) | 103 | (16) | 510 | (16) |
Total other income (loss), net | 58 | (16) | 415 | (16) |
Income (loss) from continuing operations before income taxes | (2,414) | (14,873) | (4,724) | (32,748) |
Income (loss) from discontinued operations, net of income taxes | 0 | 127,154 | (1,293) | 96,008 |
Net income (loss) | $ (2,414) | $ 112,281 | $ (6,017) | $ 63,260 |
Income (loss) per common share, basic: | ||||
Continuing operations | $ (0.24) | $ (1.7) | $ (0.47) | $ (3.77) |
Discontinued operations, net | 0 | 14.53 | (0.13) | 11.06 |
Net income (loss) per common share, basic | (0.24) | 12.83 | (0.6) | 7.29 |
Income (loss) per common share, diluted: | ||||
Continuing operations | (0.24) | (1.7) | (0.47) | (3.77) |
Discontinued operations, net | 0 | 14.53 | (0.13) | 11.06 |
Net income (loss) per common share, diluted | $ (0.24) | $ 12.83 | $ (0.6) | $ 7.29 |
Weighted average common shares, basic | 10,219 | 8,750 | 9,988 | 8,682 |
Weighted average common shares, diluted | 10,219 | 8,750 | 9,988 | 8,682 |
Comprehensive income (loss): | ||||
Net income (loss) | $ (2,414) | $ 112,281 | $ (6,017) | $ 63,260 |
Other comprehensive income | ||||
Comprehensive income (loss): | $ (2,414) | $ 112,281 | $ (6,017) | $ 63,260 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash | $ 13,729 | $ 38,067 |
Restricted cash | 11,250 | |
Royalty receivable, current portion | 841 | |
Prepaid and other current assets | 5,043 | 6,034 |
Total current assets | 19,613 | 55,351 |
Fixed assets, net | 39 | 78 |
License rights and other intangible assets, net | 6,767 | 6,943 |
Right of use assets | 7,228 | 7,580 |
Royalty receivable, long term | 19,788 | 20,253 |
Other non-current assets | 254 | 253 |
Total assets | 53,689 | 90,458 |
Current liabilities: | ||
Accounts payable | 1,508 | 2,162 |
Accrued expenses and other current liabilities | 11,484 | 18,846 |
Current liabilities of discontinued operations | 1,372 | 25,831 |
Total current liabilities | 14,364 | 46,839 |
Operating lease liabilities | 6,939 | 7,369 |
Other non-current liabilities | 1,189 | 1,107 |
Total liabilities | 22,492 | 55,315 |
Commitments and contingencies (Note 7) | ||
Stockholders' equity (deficit): | ||
Common stock, par value $0.001; 32,000 and 12,000 shares authorized, 10,575 and 9,498 issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 11 | 9 |
Additional paid-in capital | 976,566 | 974,497 |
Accumulated deficit | (945,380) | (939,363) |
Total stockholders' equity | 31,197 | 35,143 |
Total liabilities and stockholders' equity | $ 53,689 | $ 90,458 |